SITC connectED is the source for informative and engaging online education dedicated solely to cancer immunotherapy. Via this patient portal, learn the basics of immunotherapy for the treatment of a variety cancers, complete free online courses to improve your understanding of cancer immunotherapy and much more.
Through the Understanding Cancer Immunotherapy: Patient Resource Guide 5th Edition, learn the basics of the following types of cancers:
Bladder CancerHead and Neck CancerLeukemia Lung CancerMultiple MyelomaProstate Cancer
Colorectal CancerKidney (Renal) CancerLiver CancerLymphomaMelanoma and Other Skin CancersStomach (Gastric) Cancer
This interactive course provides patients and caregivers with many resources and basic education on cancer and immunotherapy. The course is designed to be self-directed and is based on the Understanding Cancer Immunotherapy - 5th Edition Patient Resource Guide. The modules cover your treatment options and providers, cancer and the immune system, types of immunotherapies, possible side effects, and links to many patient and caregiver resources.
This article is for people who want to understand how biomarkers may affect their cancer treatment choices. It's also for their care partners, and others who want to learn more about the topic. The goal is to help you know what to discuss with your healthcare team about testing for biomarkers and what the results mean for your treatment.
This article is for people who are taking an immunotherapy medicine for cancer or their caregivers who want to learn more about cancer immunotherapy. The goal is to help you know when and how to take action if you have side effects of your immunotherapy medicines.
Access All Courses
To supplement the online resources, courses and activities provided to cancer patients on this website, the Society for Immunotherapy of Cancer (SITC) also maintains a list of patient registries and surveys from partnering organizations.
A registry is a collection of information about individuals, usually focused around a specific diagnosis or condition. Participation in registries is voluntary. Registries can provide healthcare providers and researchers with valuable information to help increase understanding of a disease or condition (National Institutes of Health, 2018).
The interplay between the immune system and tumor progression is well recognized. However, current human breast cancer immunophenotyping studies are mostly focused on primary tumors with metastatic breast ...
Nivolumab, a programmed death-1 (PD-1) inhibitor, is an immune checkpoint inhibitor particularly used in the treatment of malignant melanoma, non-small cell lung cancer and renal cell carcinoma. Immune-related ...
Hepatocellular carcinoma (HCC) is the third leading cause of cancer deaths worldwide and confers a poor prognosis. Beyond standard systemic therapy with multikinase inhibitors, recent studies demonstrate ...
Continue your online learning! Browse additional free online courses in the SITC connectED Course Catalog.
The SITC connectED education portal is supported by independent educational grants from AstraZeneca Pharmaceuticals LP and Merck & Co., Inc.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com